Yüklüyor......

1410. Novel Framework to Compare the Effectiveness of Tazobactam, Relebactam and Avibactam Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

BACKGROUND: Resistance mediated by extended-spectrum β-lactamases (ESBLs) presents a serious challenge in the treatment of Gram-negative pathogens. ESBLs confer resistance to most β-lactams which may be reversed with the addition of an active β-lactamase inhibitor (such as tazobactam, relebactam and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Forum Infect Dis
Asıl Yazarlar: Abodakpi, Henrietta, Chang, Kai-Tai, Byerly, Caitlan, Tam, Vincent
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254093/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1241
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!